[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371138-105":59,"doc-detail-371138-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","role-of-tumor-microenvironment-in-cancer-promotion-development-of-drug-resistance-and-cancer-treatment","Role of tumor microenvironment in cancer promotion, development of drug resistance and cancer treatment","","Cancer is a multifactorial disease and a leading cause of death worldwide, now viewed through the lens of the tumor microenvironment (TME) rather than solely genetics. The TME includes cancer cells, endothelial cells, fibroblasts, and immune cells whose interactions promote growth, shaped by metabolic rewiring such as glutamine metabolism, aerobic glycolysis, and fatty acid metabolism. Metabolic by-products disrupt neighboring cell functions and drive progression. The review highlights metabolic crosstalk, lipid/glucose reprogramming by tumor-associated macrophages and fibroblasts, hypoxia-driven HIF-1α signaling, lactate accumulation, and resistance to anti-cancer drugs. It summarizes TME-targeted therapies, including PD-1/PD-L1 inhibitors, CAR-T cell therapy, and oncolytic viruses, and discusses clinical lactate, GLUT1, and HIF-1α monitoring to identify high-risk patients and guide personalized treatment, aiming to reduce disease burden.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-tumor-microenvironment-in-cancer-promotion-development-of-drug-resistance-and-cancer-treatment/371138/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-tumor-microenvironment-in-cancer-promotion-development-of-drug-resistance-and-cancer-treatment/371138.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the tumor microenvironment (TME) and why is it important in cancer?","Question",{"text":113,"@type":114},"TME consists of cancer cells, endothelial cells, fibroblasts, and immune cells whose interactions support tumor growth. These interactions drive cancer progression through altered metabolic mechanisms and functional disruption of surrounding cells.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does metabolic crosstalk contribute to tumor progression and drug resistance?",{"text":118,"@type":114},"Cancer-cell metabolic rewiring (e.g., glutamine metabolism, aerobic glycolysis, fatty acid metabolism) produces by-products that interfere with surrounding cells. The review also describes hypoxia-induced HIF-1α signaling that promotes lactate accumulation, supporting survival and resistance to anti-cancer drugs.",{"name":120,"@type":111,"acceptedAnswer":121},"Which therapies targeting the TME are discussed in the review?",{"text":122,"@type":114},"The review discusses PD-1 and PD-L1 inhibitors, CAR-T cell therapy, and oncolytic viruses as therapeutic approaches aimed at improving patient outcomes by targeting TME-related mechanisms.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},371138,1790211182,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Fathah and Ejaz  \nJournal of the Egyptian National Cancer Institute (2025) 37:59  \n[https://doi.org/10.1186/s43046-025-00317-8](https://doi.org/10.1186/s43046-025-00317-8)  \nJournal of the Egyptian National Cancer Institute  \n REVIEW Open Access  \nRole of tumor microenvironment in cancer   promotion, development of drug resistance and cancer treatment  \nDuaa e Fathah 1 and Samina Ejaz 1*  \nAbstract  \nCancer is a multifactorial disease and the second leading cause of death worldwide after cardiovascular disease. Initially, it was considered a genetic disease or gene expression disorder, but now it is regarded as a tumor microenvironment (TME) disease. The TME consists of cancer cells, endothelial cells, fibroblasts, and immune cells that interact with each other. These interactions support tumor growth by providing nutrients via altered metabolic mechanisms such as glutamine metabolism, aerobic glycolysis, and fatty acid metabolism. The by-products of these altered metabolic pathways interfere with the function of surrounding cells and thus lead to cancer progression. The role of metabolic crosstalk highlights the intricate relationship between the cancer cells and their TME. This review comprehensively analyzes recent studies to enhance understanding of the metabolic crosstalk inTME. It highlightshow tumor-associated macrophages and fibroblasts reprogram lipid and glucose metabolism to create an immunosuppressive environment. This review also provides information about the role of hypoxia-induced HIF-1α signaling in the promotion of lactate accumulation. This factor in turn ensures tumor cells’ survival and makes them resistant to anti-cancer drugs. Further, we have discussed therapeutic approaches targeting TME, including use of PD-1, PD-L1 inhibitors, CAR-T cell therapy, and oncolytic viruses to improve patient outcomes. Besides this, clinical studies involving the estimation of lactate, GLUT1, and HIF-1α levels may help to recognize high-risk patients and develop guidance for personalized metabolism-targeting therapies. In the long run, such studies can ultimately improve patient outcomes and thus reduce disease burden.  \nKeywords Tumor microenvironment, Cancer, Angiogenesis, CAR-T cell therapy, PD-1/PD-L1  \nIntroduction  \nCancer is the second leading cause of mortality after cardiovascular disease worldwide [1]. In 2024, reported cancer cases in the USA were 2 million along with 611,720 deaths [2]. In Pakistan, the total burden of cancer cases in 2022 was 185,748, and the mortality rate was 118,631 [3]. Cancer is a multifactorial disease, and one of its major causative factors is the altered genetic makeup. In patients, cancer progression is facilitated by mutant proteins that regulate the cell cycle, apoptosis, and DNA  \n*Correspondence:  \nSamina Ejaz [saminaejazsyed@yahoo.com](saminaejazsyed@yahoo.com)  \n1 The Islamia University of Bahawalpur, Bahawalpur, Pakistan  \nrepair processes [4]. Treatment of cancer has always been a challenging task for clinicians. Although conventional treatment methods, like chemotherapy, surgery, and radiotherapy, are in common practice, recent advancements in medical research and technology have provided clinicians with more effective therapeutic tools including targeted therapy, stem cell therapy, and ablation therapy. Besides this, nanoparticles are widely used as a delivery system across various advanced cancer therapies including immune therapy and stem cell therapy. They help enhance the targeting and bioavailability of therapeutic agents such as hyaluronic acid and natural compounds. Natural antioxidants such as curcumin, berberine, and quercetin offer anti-inflammatory and pro-apoptotic  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, pr","cbCaio1fu46W8X2z","https://ap.wps.com/l/cbCaio1fu46W8X2z","pdf",1604766,"English","# Abstract\n# Keywords\n# Introduction\n# Cancer and tumor microenvironment\n# Therapeutic approaches targeting TME\n# Metabolic markers and clinical implications","[{\"question\":\"What is the tumor microenvironment (TME) and why is it important in cancer?\",\"answer\":\"TME consists of cancer cells, endothelial cells, fibroblasts, and immune cells whose interactions support tumor growth. These interactions drive cancer progression through altered metabolic mechanisms and functional disruption of surrounding cells.\"},{\"question\":\"How does metabolic crosstalk contribute to tumor progression and drug resistance?\",\"answer\":\"Cancer-cell metabolic rewiring (e.g., glutamine metabolism, aerobic glycolysis, fatty acid metabolism) produces by-products that interfere with surrounding cells. The review also describes hypoxia-induced HIF-1α signaling that promotes lactate accumulation, supporting survival and resistance to anti-cancer drugs.\"},{\"question\":\"Which therapies targeting the TME are discussed in the review?\",\"answer\":\"The review discusses PD-1 and PD-L1 inhibitors, CAR-T cell therapy, and oncolytic viruses as therapeutic approaches aimed at improving patient outcomes by targeting TME-related mechanisms.\"}]","Role of tumor microenvironment in cancer promotion, development of drug resistance and cancer treatment | PDF",1790191335,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc467044f1508b915ea80e08492d4ebe.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/582147fe29c686326a8da0bb04c5bc2a.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d87875e7f7b8e5eda7ca3a4f4267da5.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f53680b4ca1d081151866e289e379864.webp",980,1301]